cGMP Contract Manufacturing, FDA-Registered.
Xseer Pharmaceuticals® is a U.S.-based, fully FDA-registered Contract Development and Manufacturing Organization (CDMO) delivering high-quality, cGMP-compliant manufacturing solutions across a wide range of pharmaceutical products.
We specialize in the development and production of sterile injectables, non-sterile liquids, topicals, and other complex formulations — supporting clients from preclinical development to commercial supply. Whether you’re developing a small molecule, peptide, oligonucleotide, or complex biologic, Xseer brings the infrastructure, scientific precision, and regulatory strength to move your program forward.
FDA-Registered
cGMP-Compliant
Xseer is a fully FDA-registered manufacturer and a 503B outsourcing facility, allowing us to manufacture and supply drug products at scale under FDA oversight. We uphold the highest standards in documentation, batch traceability, and process control — ensuring our partners are always inspection-ready and globally compliant.
Xseer Testing Services
Supporting 503A and 503B Release and Stability Testing
- BACT/ALERT® 3D – Real Time and Automated Microbial Detection Systems
- SCANRDI® - rapid microbial detection delivers sterility results in 4 hours or less
- Charles River Lab EndoSafe MCS Endotoxin Testing
Blog & News
Optimizing Metabolic Protocols: The Synergistic Role of Levocarnitine, L-Arginine, and Active B12
Medical weight management continues to evolve as practitioners seek safe, effective adjunctive therapies to support patients beyond standard diet and exercise r...
Read more Clinical & Technical Insights
Overcoming Formulation Challenges in Sterile Peptide Injectables and Complex Therapeutics
Peptide therapeutics and complex coenzymes represent one of the fastest-growing sectors in modern medicine. By bridging the gap between small-molecule drugs and...
Read more Case Studies & White Papers
FDA Proposes Exclusion of GLP-1s from the 503B Bulks List: Implications for Outsourcing Facilities
The U.S. Food and Drug Administration (FDA) continues to refine the regulatory framework governing compounded medications, introducing significant implications...
Read more Regulatory UpdatesPartner With a CDMO You Can Trust
From formulation to finished product, Xseer is committed to delivering regulatory clarity, technical excellence, and reliable execution.
cGMP
CURRENT GOOD
MANUFACTURING PRACTICE
FDA
FDA 503B
REGISTERED FACILITY
